Just caught Mizuho's latest take on Palantir, and there's an interesting tension here worth digging into. They lowered their price target from $205 to $195 following Q4 results, citing concerns about the stock's "extreme" valuation at 40x 2027 revenue. Fair point—that's dramatically above what you typically see in software. Yet what's striking is that the same analysts called the company's actual results "fantastic."



So what exactly happened? Palantir delivered 70% year-over-year revenue growth in Q4, and they're guiding for 61% growth in FY 2026 with a 56% free cash flow margin. Those numbers are legitimately strong. Even more impressive—their Rule of 40 score came in at 127%, which is exceptional by SaaS standards. That metric basically measures whether a company is balancing growth and profitability, and 127% means they're crushing it on both fronts.

Mizuho's Neutral rating reflects this paradox perfectly. They acknowledge Palantir is "increasingly well-positioned to benefit from long-term trends in AI, government digital transformation, and industrial modernization." The company's core business—data integration and analytics platforms for government and enterprise—is genuinely positioned in secular growth areas. Their products like Gotham and Foundry have proven track records.

But here's the catch: Mizuho expects potential "meaningful multiple reversion" in coming quarters. Translation? The valuation premium might compress as the market reprices growth expectations. It's the classic high-growth stock dilemma—spectacular execution doesn't always translate to proportional stock appreciation when you're already pricing in perfection.

The real question isn't whether Palantir's fundamentals are solid—they clearly are. It's whether the current valuation leaves room for upside or sets up investors for disappointment. That's a timing and risk tolerance call, not a quality call.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin